ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,702.55
      -0.19%
      US Tech 100
      19,287.60
      -0.24%
      Dow Jones
      42,063.36
      0.09%
      Brent Oil
      74.465
      0.79%
      Bitcoin
      63,819.11
      0.30%
      Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ

      6. NGM Biopharmaceuticals Inc (NGM) Quote

      NGM Biopharmaceuticals Inc

      NGM Biopharmaceuticals Inc (NGM)

      NASDAQ
      1.54
      0.00
      (0.00%)
      Closed September 23 4:00PM
      Delayed by 15 minutes
      0.00
      0.00
      (0.00%)
      After Hours: -
      Delayed by 15 minutes

      Empower your portfolio: Real-time discussions and actionable trading ideas.

      Premium

      Key stats and details

      Current Price
      1.54
      Bid
      1.54
      Ask
      1.35
      Volume
      -
      0.00 Day's Range 0.00
      0.6002 52 Week Range 2.20
      Previous Close
      1.54
      Open
      -
      Last Trade
      Last Trade Time
      Average Volume (3m)
      -
      Financial Volume
      -
      VWAP
      -

      Ask ADVFN Intelligence (AI)

      NGM Latest News

      More News

      NGM Bio Announces Closing of Tender Offer

      SAN FRANCISCO, April 05, 2024 (GLOBE NEWSWIRE) -- NGM Biopharmaceuticals, Inc. (“NGM Bio”) (Nasdaq: NGM), a biotechnology company focused on discovering and developing transformative...

      April 05 2024
      GlobeNewswire Inc.

      NGM Bio to Present Two Posters Highlighting Clinical Data from the Ongoing Phase 1/2 Clinical Trial of NGM707, a Dual ILT2/ILT4 Antagonist Antibody Product Candidate, at AACR 2024 Annual Meeting

      SOUTH SAN FRANCISCO, Calif., March 19, 2024 (GLOBE NEWSWIRE) -- NGM Biopharmaceuticals, Inc. (NGM Bio) (Nasdaq: NGM), a biotechnology company focused on discovering and developing transformative...

      March 19 2024
      GlobeNewswire Inc.

      Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

      March 11 2024
      Edgar (US Regulatory)

      Form 8-K - Current report

      March 11 2024
      Edgar (US Regulatory)

      NGM Bio Provides Recent Business Highlights and Reports Fourth Quarter and Full Year 2023 Financial Results

      --Enrollment ongoing for patients with microsatellite stability (MSS) colorectal cancer (CRC) in Phase1/2 trial of NGM707, a dual ILT2/ILT4 antagonist antibody product candidate, in combination...

      March 11 2024
      GlobeNewswire Inc.

      Form SC 13E3 - Going private transaction by certain issuers

      March 08 2024
      Edgar (US Regulatory)

      Form SC 14D9 - Solicitation, recommendation statements

      March 08 2024
      Edgar (US Regulatory)

      Form SC14D9C - Written communication relating to third party tender offer

      February 26 2024
      Edgar (US Regulatory)

      Form 8-K - Current report

      February 26 2024
      Edgar (US Regulatory)

      NGM Bio Has Entered into a Definitive Agreement and Plan of Merger with Certain Affiliates of The Column Group, LP

      NGM Bio stockholders to receive $1.55 per share in cash, an 80% premium over the closing share price on the last trading day prior to disclosure of receipt from The Column Group of a non-binding...

      February 26 2024
      GlobeNewswire Inc.
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      1001.541.541.5400CS
      4001.541.541.5400CS
      12001.541.541.5400CS
      26-0.01-0.6451612903231.551.631.531176441.56813277CS
      520.2822.22222222221.262.20.60025090811.30990396CS
      156-21.28-93.251533742322.8223.3650.60024509236.44487706CS
      260-14.77-90.557939914216.3132.120.600238700710.60413559CS

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      BNZIBanzai International Inc
      $ 5.645
      (96.01%)
      		61.39M
      ZJYLJin Medical International Ltd
      $ 3.975
      (50.00%)
      		1.24M
      ANEBAnebulo Pharmaceuticals Inc
      $ 2.9001
      (39.43%)
      		78.85k
      XPONExpion360 Inc
      $ 0.081
      (39.18%)
      		1.46B
      AENTAlliance Entertainment Holding Corporation
      $ 2.74
      (34.31%)
      		4.23M
      GSIWGarden Stage Ltd
      $ 1.34
      (-82.89%)
      		26.44M
      CRBPCorbus Pharmaceuticals Holdings Inc
      $ 19.51
      (-62.26%)
      		12.29M
      LGCBLinkage Global Inc
      $ 0.4183
      (-57.70%)
      		2.16M
      BFIBurgerFi International Inc
      $ 0.0855
      (-42.27%)
      		15.05M
      SKYESkye Bioscience Inc
      $ 3.17
      (-42.26%)
      		5.14M
      XPONExpion360 Inc
      $ 0.081
      (39.18%)
      		1.46B
      NVDANVIDIA Corporation
      $ 116.00
      (-1.59%)
      		378.16M
      AAPLApple Inc
      $ 228.20
      (-0.29%)
      		320.24M
      INTCIntel Corporation
      $ 21.84
      (3.31%)
      		261.68M
      VERBVerb Technology Company Inc
      $ 0.0742
      (33.45%)
      		178.65M

      NGM Discussion

      View Posts
      Monksdream Monksdream 6 months ago
      NGM under $2
      👍️0
      Monksdream Monksdream 7 months ago
      NGM under $2
      👍️0
      TrendTrade2016 TrendTrade2016 7 months ago
      NGM...NICE CLOSE AND MORE TO COME PUSHING UP AND UNDER THAT WEEKLY CLOUD!!!!
      👍️0
      TrendTrade2016 TrendTrade2016 7 months ago
      NGM...1.86 PIVOT BREAK...LITTLE BIO BEAST!!
      👍️0
      TrendTrade2016 TrendTrade2016 7 months ago
      NGM....READY AGAIN...1.86 PIVOT!
      👍️0
      TrendTrade2016 TrendTrade2016 8 months ago
      NGM...HERE WE GO BREAKING 1.73....2.39 PIVOT UP A HEAD
      👍️0
      TrendTrade2016 TrendTrade2016 8 months ago
      NGM..NEXT STOP 1.73
      👍️0
      TrendTrade2016 TrendTrade2016 8 months ago
      NGM..HERE WE GO
      👍️0
      TrendTrade2016 TrendTrade2016 8 months ago
      NGM...THIS ONE WILL SHOCK THE BIO SCENE
      👍️0
      TrendTrade2016 TrendTrade2016 8 months ago
      NGM...MONSTER IN THE MAKING
      👍️0
      TrendTrade2016 TrendTrade2016 8 months ago
      WATCH AND LEARN...1.45 BREAK AND WE ARE OFF
      👍️0
      Nadendla Nadendla 9 months ago
      Bionic quicksand just around the corner..
      👍️0
      MiamiGent MiamiGent 9 months ago
      NGM Taking a stab here. Dangerous play

      $1.21 +0https://investorshub.advfn.com/boards/edit_msg.aspx?message_id=173543744.351 (+40.86%)

      https://stockcharts.com/h-sc/ui?s=NGM

      Ngm Biopharmaceuticals Confirmed It Received A Non-Binding Expression Of Interest From The Column Group Regarding Potential Acquisition Of All Outstanding Shares Of Common Stock Of The Company Not Already Owned By TCG In A Going-Private Transaction
      BENZINGA
      7:36 AM ET Jan-02-2024
      NGM Biopharmaceuticals, Inc. (NGM.NaE) today confirmed that it has received a non-bindingexpression of interest dated December 28, 2023 (the "EOI") from The Column Group,
      NGM Biopharmaceuticals, Inc. (NGM.NaE) today confirmed that it has received a non-bindingexpression of interest dated December 28, 2023 (the "EOI") from The Column Group, LP and certain affiliated investment funds and persons (collectively, "TCG"), outlining TCG's intent to explore and evaluate a potential acquisition of all of the outstanding shares of common stock of the Company not already owned by TCG in a going-private transaction. TCG currently beneficially owns approximately 26.7% of the outstanding shares of NGM Bio's common stock. A copy of the EOI is attached to TCG's amended Schedule 13D filed with the Securities and Exchange Commission on December 29, 2023.

      In response to the EOI, the Company's Board of Directors has formed a special committee consisting of disinterested and independent directors to consider the EOI and any other strategic alternatives that may be available to the Company, including remaining a standalone publicly-traded company. The special committee has retained Hogan Lovells US LLP as its independent legal advisor, and intends to retain an independent financial advisor, to assist it in considering the EOI. Cooley LLP is acting as legal advisor to the Company.
      👍️0
      TrendTrade2016 TrendTrade2016 9 months ago
      NGM...BIO BEAST SEES A 1.84 EXIT INTO BIOVILLE
      👍️0
      TrendTrade2016 TrendTrade2016 9 months ago
      NGM...MASSIVE BIO BEAST VOLUME
      👍️0
      TrendTrade2016 TrendTrade2016 9 months ago
      NGM...BIO BOTTOM BEAST READY TO BEAST THROUGH BIOVILLE
      👍️0
      Monksdream Monksdream 11 months ago
      NGM new 52 week low
      👍️0
      Monksdream Monksdream 12 months ago
      NGM under $2
      👍️0

      Your Recent History

      NASDAQ
      NGM
      NGM Biopharmaceuticals
      Delayed Upgrade Clock